SALIX PHARMACEUTICALS LTD·4

Jul 3, 4:24 PM ET

SALIX PHARMACEUTICALS LTD 4

4 · SALIX PHARMACEUTICALS LTD · Filed Jul 3, 2014

Insider Transaction Report

Form 4
Period: 2014-07-01
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    2014-07-01$123.35/sh8,253$1,018,008613,154.2 total
Holdings
  • Common Stock

    (indirect: By GRAT)
    400,000
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (44,000 underlying)
    44,000
Footnotes (2)
  • [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
  • [F2]Options are 100% vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION